Dr. Kamran Khan, MD, MPH, is a practising infectious disease physician and a Professor of Medicine and Public Health at the University of Toronto, where he holds a Temerty Health Nexus Chair in Innovation and Technology. Motivated by his experiences as a frontline healthcare worker during the 2003 Toronto SARS outbreak, Kamran has been studying outbreaks of emerging and re-emerging pathogens for nearly two decades to lay the scientific foundation for a global early warning system for infectious diseases. His research has been published in leading scientific journals from the New England Journal of Medicine, the Lancet, Science, Nature, and Cell. Kamran’s work during global health emergencies such as the 2014 Ebola epidemic in West Africa and the 2016 Zika epidemic in Latin America has led him into numerous advisory roles from the World Health Organization to the White House.
To translate and disseminate scientific knowledge into timely action, Dr. Khan spun off BlueDot in 2013, a biothreat intelligence company that combines human and artificial intelligence to help governments protect their citizens, and businesses protect their operations, employees and customers from disruptive infectious disease threats. BlueDot has been featured in global forums such as CNN, BBC World, and CBS’ 60 Minutes. Kamran’s work transcending clinical medicine, public health, big data, and artificial intelligence has been recognized with a University of Toronto’s President’s Impact Award and a Governor General’s Award.
Kamran is passionate about drawing from his experiences spanning the bedside to bench to boardroom to mentor aspiring health innovators and entrepreneurs.